​

Checkpoint Therapeutics Ownership | Who Owns Checkpoint Therapeutics?

OverviewForecastRevenueFinancialsChart

Checkpoint Therapeutics Ownership Summary

Checkpoint Therapeutics is owned by 5.63% institutional investors, and 94.37% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.24% of its assets in Checkpoint Therapeutics shares.

CKPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCheckpoint Therapeutics5.63%-94.37%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20231-661,597-5-1---
Sep 30, 202258-4.92%11,394,32314.27%129.91%16-5.88%13-23.53%
Jun 30, 202261-15.28%9,971,262-22.59%114.97%17-55.26%1721.43%
Mar 31, 2022727.46%12,880,86219.42%158.03%3831.03%14-12.50%
Dec 31, 202167-1.47%10,785,8211.98%137.57%29-14.71%166.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.09M2.24%-
Vanguard Institutional Extnd Mkt Idx Tr732.70K1.50%253.05K
Fidelity Extended Market Index208.21K0.43%-1.37K
Extended Equity Market Fund K93.53K0.19%40.78K
iShares Micro-Cap ETF76.30K0.16%-
Fidelity Total Market Index70.28K0.14%-
BlackRock Extended Equity Market K52.75K0.12%-22.00
Fidelity Series Total Market Index49.04K0.10%-419.00
Fidelity Nasdaq Composite Index48.40K0.10%-
NT Ext Equity Mkt Idx Fd - L44.82K0.09%10.23K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 18, 2024Oliviero James F III CEO, President and DirectorSell$2.33M
Dec 19, 2024Oliviero James F III CEO, President and DirectorSell$744.38K
Dec 18, 2024GRAY WILLIAM GARRETT Chief Financial OfficerSell$1.08M
Jun 26, 2024Oliviero James F III CEO, President and DirectorSell$50.45K
Jun 26, 2024GRAY WILLIAM GARRETT Chief Financial OfficerSell$26.86K

Insider Transactions Trends

DateBuySell
2024 Q4-3
2024 Q3--
2024 Q2-2
2024 Q1-4
2023 Q4--

CKPT Ownership FAQ

Who Owns Checkpoint Therapeutics?

Checkpoint Therapeutics shareholders are primarily institutional investors at 5.63%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Checkpoint Therapeutics's industry, Biotech Stocks , is 109.70%, which Checkpoint Therapeutics falls below.

Does Blackrock own Checkpoint Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Checkpoint Therapeutics.

Who is the top mutual fund holder of Checkpoint Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Checkpoint Therapeutics shares, with 2.24% of its total shares outstanding invested in 1.09M Checkpoint Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools